MARKET

HMDCF

HMDCF

HUTCHMED (China) Limited
OTCPK
2.900
NaN%
Closed 09:30 02/13 EST
OPEN
--
PREV CLOSE
2.900
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.900
52 WEEK LOW
2.900
MARKET CAP
2.53B
P/E (TTM)
5.42
1D
5D
1M
3M
1Y
5Y
1D
HUTCHMED to Announce 2025 Final Results
Barchart · 02/06 02:30
HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
Barchart · 01/13 22:00
HUTCHMED Announces Positive Topline Results of Phase III Part of ESLIM-02 Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China
Barchart · 01/06 18:00
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting
Barchart · 11/26/2025 18:00
HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event
Barchart · 11/02/2025 18:00
HUTCHMED Highlights HMPL-A251 Data Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Barchart · 10/22/2025 19:00
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
Barchart · 10/14/2025 03:30
HUTCHMED Highlights FRUSICA-2 Registration Trial Data to be Presented at the 2025 ESMO Congress
Barchart · 10/12/2025 23:00
More
About HMDCF
HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.

Webull offers HUTCHMED (China) Ltd stock information, including OTCPK: HMDCF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HMDCF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HMDCF stock methods without spending real money on the virtual paper trading platform.